The N-methyl-D-aspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: Evidence for modulation by cation-π interactions

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 1, 2004, Pages 14-21

  Raines, Douglas E ^a   Gioia, Fredrick ^a   Claycomb, Robert J ^a   Stevens, Renna J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIFLUOROBENZENE; 1,2,4 TRIFLUOROBENZENE; 1,3,5 TRIFLUOROBENZENE; 1,4 DIFLUOROBENZENE; AROMATIC COMPOUND; BENZENE; ETHYLBENZENE; FLUOROBENZENE; META XYLENE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORTHO XYLENE; PARA XYLENE; PENTAFLUOROBENZENE; PENTAFLUOROTOLUENE; PERFLUOROBENZENE; TOLUENE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DRUG ABUSE; DRUG BINDING SITE; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; GAS PARTITION COEFFICIENT; GENERAL ANESTHESIA; HYDROPHOBICITY; MOLECULAR MODEL; NONHUMAN; OOCYTE; PARTITION COEFFICIENT; PRIORITY JOURNAL; XENOPUS;

ANIMALS; CATIONS; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; HYDROCARBONS, AROMATIC; OCTANOLS; OOCYTES; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 4644353582     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.069930     Document Type: Article

References (48)

1. Abraham MH, Lieb WR, and Franks NP (1991) Role of hydrogen bonding in general anesthesia. J Pharm Sci 80:719-724.
2. Balster RL (1998) Neural basis of inhalant abuse. Drug Alcohol Depend 51:207-214.
3. Beene DL, Brandt GS, Zhong W, Zacharias NM, Lester HA, and Dougherty DA (2002) Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry 41:10262-10269.
4. Chase TN, Oh JD, and Konitsiotis S (2000) Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms. J Neurol 247 (Suppl 2):II36-II42.
5. Coyle JT, Tsai G, and Goff DC (2002) Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Target CNS Neurol Disord 1:183-189.
6. Cruz SL, Balster RL, and Woodward JJ (2000) Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br J Pharmacol 131:1303-1308.
7. Cruz SL, Mirshahi T, Thomas B, Balster RL, and Woodward JJ (1998) Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 286:334-340.
8. de Sousa SL, Dickinson R, Lieb WR, and Franks NP (2000) Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology 92:1055-1066.
9. Eckenhoff RG and Johansson JS (1997) Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev 49:343-367.
10. Fang Z, Ionescu P, Chortkoff BS, Kandel L, Sonner J, Laster MJ and Eger EI 2nd (1997) Anesthetic potencies of n-alkanols: results of additivity and solubility studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth Analg 84:1042-1048.
11. Fang Z, Sonner J, Laster MJ, Ionescu P, Kandel L, Koblin DD, Eger EI 2nd, and Halsey MJ (1996) Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis. Anesth Analg 83:1097-1104.
12. Firestone LL, Alifimoff JK, and Miller KW (1994) Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering? Mol Pharmacol 46:508-515.
13. Franks NP and Lieb WR (1994) Molecular and cellular mechanisms of general anaesthesia. Nature (Land) 367:607-614.
14. Gursky O, Fontano E, Bhyravbhatla B, and Caspar DL (1994) Stereospecific dihaloalkane binding in a pH-sensitive cavity in cubic insulin crystals. Proc Natl Acad Sci USA 91:12388-12392.
15. Hollmann MW, Liu HT, Hoenemann CW, Liu WH, and Durieux ME (2001) Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Anesth Analg 92:1182-1191.
16. Jenkins A, Greenblatt EP, Faulkner HJ, Bertaccini E, Light A, Lin A, Andreasen A, Viner A, Trudell JR, and Harrison NL (2001) Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci 21: RC136(1-4).
17. Johansson JS and Zou H (1999) Partitioning of four modern volatile general anesthetics into solvents that model buried amino acid side-chains. Biophys Chem 79:107-116.
18. Kemp JA and McKernan RM (2002) NMDA receptor pathways as drug targets. Nat Neurosci 5 (Suppl):1039-1042.
19. Koblin DD, Fang Z, Eger EI, 2nd, Laster MJ, Gong D, Ionescu P, Halsey MJ, and Trudell JR (1998) Minimum alveolar concentrations of noble gases, nitrogen and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 87:419-424.
20. Liu R, Pidikiti R, Ha CE, Petersen CE, Bhagavan NV, and Eckenhoff RG (2002) The role of electrostatic interactions in human serum albumin binding and stabilization by halothane. J Biol Chem 277:36373-36379.
21. Manderson GA and Johansson JS (2002) Role of aromatic side chains in the binding of volatile general anesthetics to a four-alpha-helix bundle. Biochemistry 41:4080-4087.
22. Mascia MP, Machu TK, and Harris RA (1996) Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br J Pharmacol 119:1331-1336.
23. Massey GM and Jackson SR (1973) Clinical anaesthesia with hexafluorobenzene in the dog. Anaesthesia 28:327-330.
24. Mecozzi S, West AP Jr, and Dougherty DA (1996) Cation-pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide. Proc Natl Acad Sci USA 93:10566-10571.
25. Meyer H (1899) Theorie der alkoholnarkose. Arch Exp Pathol Phamakol 42:109-118.
26. Mihic SJ, McQuilkin SJ, Eger EI 2nd, Ionescu P, and Harris RA (1994) Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia. Mol Pharmacol 46:851-857.
27. Moss GW, Curry S, Franks NP, and Lieb WR (1991) Mapping the polarity profiles of general anesthetic target sites using n-alkane-(alpha, omega)-diols. Biochemistry 30:10551-10557.
28. Neal MJ and Robson JM (1966) The analgesic and anaesthetic actions of tetrafluorobenzene. Br J Pharmacol 26:482-493.
29. Orser BA, Pennefather PS, and MacDonald JF (1997) Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 86:903-917.
30. Overton E (1901) Studien uber die narkose zugleich ein beitrag zur allgemein pharmakologie, Jena, Germany.
31. Peoples RW and Ren H (2002) Inhibition of N-methyl-D-aspartate receptors by straight-chain diols: implications for the mechanism of the alcohol cutoff effect. Mol Pharmacol 61:169-176.
32. Peoples RW and Weight FF (1995) Cutoff in potency implicates alcohol inhibition of N-methyl-D-aspartate receptors in alcohol intoxication. Proc Natl Acad Sci USA 92:2825-2829.
33. Peoples RW, White G, Lovinger DM, and Weight FF (1997) Ethanol inhibition of N-methyl-D-aspartate-activated current in mouse hippocampal neurones: whole-cell patch-clamp analysis. Br J Pharmacol 122:1035-1042.
34. Raines DE and Claycomb RJ (2002) The role of electrostatic interactions in governing anesthetic action on the torpedo nicotinic acetylcholine receptor. Anesth Analg 95:356-361.
35. Raines DE, Claycomb RJ, and Forman SA (2002) Nonhalogenated anesthetic alkanes and perhalogenated nonimmobilizing alkanes inhibit alpha(4)beta(2) neuronal nicotinic acetylcholine receptors. Anesth Analg 95:573-577.
36. Raines DE, Claycomb RJ, and Forman SA (2003) Modulation of GABA(A) receptor function by nonhalogenated alkane anesthetics: the effects on agonist enhancement, direct activation and inhibition. Anesth Analg 96:112-118.
37. Raines DE, Claycomb RJ, Scheller M, and Forman SA (2001) Nonhalogenated alkane anesthetics fail to potentiate agonist actions on two ligand-gated ion channels. Anesthesiology 95:470-477.
38. Sonner JM, Li J, and Eger EI (1998) Desflurane and the nonimmobilizer 1,2-dichlorohexafluorocyclobutane suppress learning by a mechanism independent of the level of unconditioned stimulation. Anesth Analg 87:200-205.
39. Tang P, Eckenhoff RG, and Xu Y (2000) General anesthetic binding to gramicidin Ar the structural requirements. Biophys J 78:1804-1809.
40. Watts A (2002) Direct studies of ligand-receptor interactions and ion channel blocking. Mol Membr Biol 19:267-275.
41. Wick MJ, Mihic SJ, Ueno S, Mascia MP, Trudell JR, Brozowski SJ, Ye Q, Harrison NL, and Harris RA (1998) Mutations of gamma-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc Natl Acad Sci USA 95:6504-6509.
42. Wood SC, Forman SA, and Miller KW (1991) Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo. Mol Pharmacol 39:332-338.
43. Wood SC, Hill WA, and Miller KW (1993) Cycloalkanemethanols discriminate between volume- and length-dependent loss of activity of alkanols at the Torpedo nicotinic acetylcholine receptor. Mol Pharmacol 44:1219-1226.
44. Yamakura T and Harris RA (2000) Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels: comparison with isoflurane and ethanol. Anesthesiology 93:1095-1101.
45. Zacharias N and Dougherty DA (2002) Cation-pi interactions in ligand recognition and catalysis. Trends Pharmacol Sci 23:281-287.
46. Zhang Y, Trudell JR, Mascia MP, Laster MJ, Gong DH, Harris RA, and Eger EI (2000) The anesthetic potencies of alkanethiols for rats: relevance to theories of narcosis. Anesth Analg 91:1294-1299.
47. Zhong W, Gallivan JP, Zhang Y, Li L, Lester HA, and Dougherty DA (1998) From ab initio quantum mechanics to molecular neurobiology: a cation-pi binding site in the nicotinic receptor. Proc Natl Acad Sci USA 95:12088-12093.
48. - current correlates with in vivo anesthetic potency. J Pharmacol Exp Ther 270:987-991.